+1 (202) 780-3397
Rapid Communication - Journal of Molecular Oncology Research (2023) Volume 7, Issue 1
Development of extra cranial germ cell tumour and their inhibition
Germ cell tumours (GCTs) arising in infants, children, and adolescents present a set of special challenges. GCTs make up about 3% of malignancies in children aged 0–18 and nearly 15% of cancers in adolescents. Epidemiologic and molecular evidence suggests that GCTs in young children likely represent a distinct biologic group as compared to GCTs of older adolescents and adults. Despite this difference, pediatric GCTs are typically treated with cisplatin-based multiagent regimens similar to those used in adults.
Author(s): Daniel Pearce